HER2-Positive Breast Cancer—Reduce Your Risk of Recurrence | Access Health
![](https://i.ytimg.com/vi/QS-1HZr-trg/mqdefault.jpg)
1:27:01
Q&A: Is Less More - Rethinking Breast Cancer Treatment
![](https://i.ytimg.com/vi/nNN94Bj9uyg/mqdefault.jpg)
1:05:11
Ask the expert: Early-stage HER2-positive breast cancer with Adrienne Waks, MD
![](https://i.ytimg.com/vi/sZK3ADJk_Vs/mqdefault.jpg)
15:11
Learn Your Breast Cancer Recurrence Risk and Personalize Your Treatment With This Vital Test
![](https://i.ytimg.com/vi/i4dHP1RebPo/mqdefault.jpg)
13:09
EVERYTHING you need to know About Herceptin Treatment...
![](https://i.ytimg.com/vi/Nl25qQGz-Lw/mqdefault.jpg)
27:38
'Triple-neg breast cancer is aggressive, and we need to be aggressive back’ | TNBC Project
![](https://i.ytimg.com/vi/t6JcIohjSdE/mqdefault.jpg)
38:06
Bu Besini İlaç Kullanırken Tüketmeyin! Genetik Testler Hayat Kurtarır mı? Yavuz Dizdar Asuman Uğur
![](https://i.ytimg.com/vi/qigYa-5wLik/mqdefault.jpg)
20:17
Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and Toxicity
![](https://i.ytimg.com/vi/tR_nsQTciTw/mqdefault.jpg)
27:27